Recent Updates
Recently added Catalysts
PTN Positive Sentiment Score: 75/100

Palatin to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Thursday, September 7, 2023 1 min read
Key Takeaway: Palatin Technologies, Inc. will present at the H.C. Wainwright 25th Annual Global Investment Conference from September 11-13, 2023. The presentation is scheduled for September 13, 2023, at 10:00 a.m. ET, with a live webcast available on the company's investor website. Palatin develops first-in-class biopharmaceutical medicines targeting melanocortin receptor systems aimed at addressing significant unmet medical needs. The company also plans to form marketing collaborations to enhance the commercial potential of its products.

Market Sentiment Analysis

POSITIVE FACTORS

  • Palatin is presenting at a noteworthy investment conference.
  • The company is developing first-in-class biopharmaceutical products.
  • Palatin's strategic focus includes forming collaborations for product commercialization.

Full Press Release Details

CRANBURY, N.J., Sept. 7, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that management will present at H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023 in New York, NY.
The Company presentation will be held on Wednesday, September 13, 2023 at 10:00 a.m. ET. A live webcast of the presentation will be available on the Investors section of Palatin's website at http://www.palatin.com. A replay of the webcast will be available for 30 days following the presentation.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
SOURCE Palatin Technologies, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Palatin Technologies present at the H.C. Wainwright Conference?

Palatin Technologies will present on September 13, 2023, at 10:00 a.m. ET.

How can I watch Palatin's conference presentation?

You can watch the live webcast on Palatin's Investors section of their website.

What is the focus of Palatin Technologies?

Palatin develops first-in-class medicines targeting the melanocortin receptor system.

Is there a replay available for the conference presentation?

Yes, a replay of the webcast will be available for 30 days after the event.

What is Palatin's commercialization strategy?

Palatin aims to develop products and form marketing collaborations with industry leaders.

Tags: PTN Viatris Investor Conferences Healthcare Palatin Technologies biopharmaceuticals melanocortin receptors investment conference
Last updated: Sep 7, 2023